Single-Center Experience with Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis against SARS-CoV-2 Infection in Kidney and Pancreas Transplant Recipients

Authors

Milisha Shah PharmD, BCPS, BCTXP, Lehigh Valley Health NetworkFollow
Hope Kincaid MPH, CPH, Lehigh Valley Health NetworkFollow
Alison Sutter MPH, Lehigh Valley Health NetworkFollow
Christine Du MD, Lehigh Valley Health NetworkFollow
Patty Liu MD, Lehigh Valley Health NetworkFollow
Michael J. Moritz MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

4-2023

Comments

Copyright © Lehigh Valley Health Network

Published In/Presented At

Shah, M., Kincaid, H., Sutter, A., Du, C., Liu. P., & Moritz, M. (2023). Single-Center Experience with Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis against SARS-CoV-2 Infection in Kidney and Pancreas Transplant Recipients [Poster]. Poster presented at Lehigh Valley Health Network, Allentown, PA.

Disciplines

Medicine and Health Sciences | Pharmacy and Pharmaceutical Sciences

Department(s)

Department of Pharmacy, Department of Surgery, Network Office of Research and Innovation

Document Type

Poster